CV
Claris Ventures at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Claris Ventures takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions look at new frontiers in immunology and at the respiratory market beyond the inhaler. The respiratory session is shared with Chiesi, Vicore Pharma and Novo Holdings.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
CV Claris Ventures | |
Italian venture capital firm investing in early-stage biotech companies. | Panel Tue Nov 10 14:00–14:45 Immunology under the microscope: New frontiers What is new in drugs for autoimmune and inflammatory diseases: emerging targets, recent trial results, and where companies are investing and partnering. Panel Wed Nov 11 09:00–09:45 Beyond the inhaler: The respiratory market New drugs and targets for asthma, chronic obstructive lung disease and pulmonary fibrosis, and where investors and partners are now putting money. |
Instantly find 20 buyers from Claris Ventures
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction